APA (7th ed.) Citation

CE, G., P, J., R, B., WM, S., U, S., SH, S., & CG, R. (2018). CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma. Cytometry. Part B, Clinical cytometry, 94(1), 129. https://doi.org/10.1002/cyto.b.21384

Chicago Style (17th ed.) Citation

CE, Gooden, Jones P, Bates R, Shallenberger WM, Surti U, Swerdlow SH, and Roth CG. "CD49d Shows Superior Performance Characteristics for Flow Cytometric Prognostic Testing in Chronic Lymphocytic Leukemia/small Lymphocytic Lymphoma." Cytometry. Part B, Clinical Cytometry 94, no. 1 (2018): 129. https://doi.org/10.1002/cyto.b.21384.

MLA (9th ed.) Citation

CE, Gooden, et al. "CD49d Shows Superior Performance Characteristics for Flow Cytometric Prognostic Testing in Chronic Lymphocytic Leukemia/small Lymphocytic Lymphoma." Cytometry. Part B, Clinical Cytometry, vol. 94, no. 1, 2018, p. 129, https://doi.org/10.1002/cyto.b.21384.